NTC
North Tide Capital Portfolio holdings
AUM
$469M
This Quarter Return
-1.68%
1 Year Return
+6.55%
3 Year Return
+14.78%
5 Year Return
–
10 Year Return
–
AUM
$1.31B
AUM Growth
+$1.31B
(-8.2%)
Cap. Flow
-$78.6M
Cap. Flow
% of AUM
-5.99%
Top 10 Holdings %
Top 10 Hldgs %
63.75%
Holding
29
New
3
Increased
6
Reduced
4
Closed
4
Top Buys
| 1 |
AbbVie
ABBV
|
$86.6M |
| 2 |
Viatris
VTRS
|
$68.2M |
| 3 |
GHDX
Genomic Health, Inc.
GHDX
|
$34M |
| 4 |
KND
Kindred Healthcare
KND
|
$34M |
| 5 |
FRED
Fred's Inc
FRED
|
$21M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$67.2M |
| 2 |
Elevance Health
ELV
|
$64.6M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$53.8M |
| 4 |
SVU
SUPERVALU Inc.
SVU
|
$49.2M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$48.3M |
Sector Composition
| 1 | Healthcare | 81.84% |
| 2 | Consumer Discretionary | 6.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Select Medical
SEM
$1.61B
| $168M | 12.78% | 13,950,000 | – | – |
|
|
2
Teva Pharmaceuticals
TEVA
$21.1B
| $108M | 8.19% | 2,000,000 -1,000,000 | -33% | -$53.8M |
|
|
3
AbbVie
ABBV
$372B
| $86.6M | 6.6% | +1,500,000 | New | +$86.6M |
|
|
AMED
4
DELISTED
Amedisys
AMED
| $80.7M | 6.15% | 4,000,000 | – | – |
|
5
Edwards Lifesciences
EW
$47.8B
| $76.6M | 5.84% | 750,000 +150,000 | +25% | +$15.3M |
|
|
6
Viatris
VTRS
$12.3B
| $68.2M | 5.2% | +1,500,000 | New | +$68.2M |
|
7
Bausch Health
BHC
$2.74B
| $65.6M | 5% | 500,000 | – | – |
|
|
KND
8
DELISTED
Kindred Healthcare
KND
| $63.1M | 4.8% | 3,250,000 +1,750,000 | +117% | +$34M |
|
|
TVTY
9
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $61.7M | 4.7% | 3,850,000 | – | – |
|
10
Boston Scientific
BSX
$156B
| $59.1M | 4.5% | 5,000,000 | – | – |
|
11
Orthofix Medical
OFIX
$592M
| $55.7M | 4.25% | 1,800,000 | – | – |
|
|
WW
12
DELISTED
WW International
WW
| $54.9M | 4.18% | 2,000,000 | – | – |
|
|
GHDX
13
DELISTED
Genomic Health, Inc.
GHDX
| $42.5M | 3.23% | 1,500,000 +1,200,000 | +400% | +$34M |
|
|
VVUS
14
DELISTED
Vivus Inc
VVUS
| $38.6M | 2.94% | 10,000,000 +1,000,000 | +11% | +$3.86M |
|
15
Myriad Genetics
MYGN
$593M
| $38.6M | 2.94% | 1,000,000 | – | – |
|
|
GTIV
16
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $33.6M | 2.56% | 2,000,000 +1,250,000 | +167% | +$21M |
|
17
Quest Diagnostics
DGX
$20.3B
| $30.3M | 2.31% | 500,000 -500,000 | -50% | -$30.3M |
|
|
ELOS
18
DELISTED
Syneron Medical Ltd
ELOS
| $30.1M | 2.29% | 3,000,000 | – | – |
|
|
AFAM
19
DELISTED
Almost Family Inc
AFAM
| $29.6M | 2.26% | 1,090,500 | – | – |
|
|
MNTA
20
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $28.4M | 2.16% | 2,500,000 | – | – |
|
|
MGLN
21
DELISTED
Magellan Health Services, Inc.
MGLN
| $27.4M | 2.08% | 500,000 | – | – |
|
|
SVU
22
DELISTED
SUPERVALU Inc.
SVU
| $26.8M | 2.04% | 3,000,000 -5,500,000 | -65% | -$49.2M |
|
|
FRED
23
DELISTED
Fred's Inc
FRED
| $21M | 1.6% | +1,500,000 | New | +$21M |
|
24
Accuray
ARAY
$157M
| $14.5M | 1.11% | 2,000,000 +1,000,000 | +100% | +$7.26M |
|
|
NUVA
25
DELISTED
NuVasive, Inc.
NUVA
| $4.01M | 0.31% | 115,000 -1,385,000 | -92% | -$48.3M |
|